Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A glucagon-like peptide-1 agonist drug under investigation for treatment of diabetes.

Etymologies

Sorry, no etymologies found.

Examples

  • Another drug, albiglutide, is also undergoing testing in a large clinical trial.

    Glaxo Looks for Gene-Research Payoff on Other Drugs

  • There are already two similar drugs on the market, so albiglutide would have to demonstrate significantly better efficacy or safety if it is to gain market share.

    Glaxo Looks for Gene-Research Payoff on Other Drugs

  • In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, in Phase 3 development in patients with coronary heart disease, and Syncria® (albiglutide), in Phase 3 development in patients with type 2 diabetes.

    BioSpace.com Featured News and Stories

  • Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight

    THE MEDICAL NEWS

  • Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight

    THE MEDICAL NEWS

  • In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and Syncria® (albiglutide), currently in Phase 3 development as a potential treatment for type 2 diabetes.

    BioSpace.com Featured News and Stories

  • In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and Syncria® (albiglutide), currently in Phase 3 development as a potential treatment for type 2 diabetes.

    BioSpace.com Featured News and Stories

  • In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development in patients with coronary heart disease, and Syncria (r) (albiglutide), currently in Phase 3 development in patients with type 2 diabetes.

    News

  • In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development in patients with coronary heart disease, and Syncria (R) (albiglutide), currently in Phase 3 development in patients with type 2 diabetes.

    Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7

  • In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development in patients with coronary heart disease, and Syncria® (albiglutide), currently in Phase 3 development in patients with type 2 diabetes.

    undefined

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.